Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
- PMID: 20190758
- DOI: 10.1038/ni.1848
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
Abstract
Cross-priming allows dendritic cells (DCs) to induce cytotoxic T cell (CTL) responses to extracellular antigens. DCs require cognate 'licensing' for cross-priming, classically by helper T cells. Here we demonstrate an alternative mechanism for cognate licensing by natural killer T (NKT) cells recognizing microbial or synthetic glycolipid antigens. Such licensing caused cross-priming CD8alpha(+) DCs to produce the chemokine CCL17, which attracted naive CTLs expressing the chemokine receptor CCR4. In contrast, DCs licensed by helper T cells recruited CTLs using CCR5 ligands. Thus, depending on the type of antigen they encounter, DCs can be licensed for cross-priming by NKT cells or helper T cells and use at least two independent chemokine pathways to attract naive CTLs. Because these chemokines acted synergistically, this can potentially be exploited to improve vaccinations.
Comment in
-
Signal 0 for guided priming of CTLs: NKT cells do it too.Nat Immunol. 2010 Apr;11(4):284-6. doi: 10.1038/ni0410-284. Nat Immunol. 2010. PMID: 20300136 Review. No abstract available.
Similar articles
-
Signal 0 for guided priming of CTLs: NKT cells do it too.Nat Immunol. 2010 Apr;11(4):284-6. doi: 10.1038/ni0410-284. Nat Immunol. 2010. PMID: 20300136 Review. No abstract available.
-
Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.J Immunol. 2015 Aug 1;195(3):821-31. doi: 10.4049/jimmunol.1401751. Epub 2015 Jun 15. J Immunol. 2015. PMID: 26078270
-
Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of α-galactosylceramide in vivo.Immunology. 2017 Jul;151(3):324-339. doi: 10.1111/imm.12733. Epub 2017 Apr 18. Immunology. 2017. PMID: 28294313 Free PMC article.
-
Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.J Med Assoc Thai. 2010 Jan;93 Suppl 1:S62-70. J Med Assoc Thai. 2010. PMID: 20364559
-
The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.Int J Mol Sci. 2017 Nov 2;18(11):2306. doi: 10.3390/ijms18112306. Int J Mol Sci. 2017. PMID: 29099057 Free PMC article. Review.
Cited by
-
CCL17-expressing dendritic cells in the intestine are preferentially infected by Salmonella but CCL17 plays a redundant role in systemic dissemination.Immun Inflamm Dis. 2021 Sep;9(3):891-904. doi: 10.1002/iid3.445. Epub 2021 May 4. Immun Inflamm Dis. 2021. PMID: 33945673 Free PMC article.
-
Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice.PLoS One. 2010 Dec 29;5(12):e15680. doi: 10.1371/journal.pone.0015680. PLoS One. 2010. PMID: 21206747 Free PMC article.
-
T-cell positioning by chemokines in autoimmune skin diseases.Immunol Rev. 2019 May;289(1):186-204. doi: 10.1111/imr.12762. Immunol Rev. 2019. PMID: 30977191 Free PMC article. Review.
-
Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells.Front Immunol. 2017 Jul 31;8:886. doi: 10.3389/fimmu.2017.00886. eCollection 2017. Front Immunol. 2017. PMID: 28824620 Free PMC article. Review.
-
Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.Oncoimmunology. 2017 Aug 18;6(9):e1339855. doi: 10.1080/2162402X.2017.1339855. eCollection 2017. Oncoimmunology. 2017. PMID: 28932640 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases